Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 2Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Castration-Resistant Prostate Cancer (CRPC) 1

Interventions

Fluorodeoxyglucose F18 2sacituzumab govitecan 1pembrolizumab 1lenvatinib 1erdafitinib 1enfortumab vedotin 1avelumab 1Vinblastine 1Paclitaxel 1Oxaliplatin 1Nivolumab 1Methotrexate 1Gemcitabine 1Counseling 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Enrolling by invitation × Counseling × Clear all
NCT07240857 2026-05-22

A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T Cells in the Treatment of Castration-Resistant Prostate Cancer

Zhejiang University

Phase EARLY_PHASE1 Enrolling by invitation
18 enrolled
Genitourinary

Castration-Resistant Prostate Cancer (CRPC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡